Codex Center

Facebook Linkedin
Contact Us

At Codex Labs, we are following all current advice provided by the Egyptian Government, local health authorities and the World Health Organization (WHO), and taking extra precautionary steps to ensure the health and safety of our laboratory staff and customer service team to minimize any disruption to testing.

We understand that the healthcare system is stretched, and as such some patients may feel isolated and not sure of where to turn. We are not directly involved with COVID-19 testing, thus able to continue our core business – which is providing state-of-the art diagnostic testing for both newly diagnosed cancer patients or patients that are dealing with a recurrence.

We also understand that for many of our patients and their family and friends, we understand that you may be wondering how best to protect yourself during this time. Codex Labs is pleased to be able to supply our patients with Care Packs, containing surgical grade masks and gloves.

Please be advised our laboratory is still operational, and we are currently not experiencing any delays with processing of samples.

We have many tests available, some which can be used to track your progress using a simple blood draw as well as monitor your immune system both during and after treatment. We have access to a group of oncologists that can help interpret results for you via tele-health consultations. We also have access to integrative medicine specialists who can assist with your navigation through the health maze. For patients located in Cairo, we can also help arrange home visits for collection of your blood sample for testing.

Please call us on +201001413179 for more information on how we can help.

 
Contact Us

About Us

WHY WE’RE DIFFERENT
EXCLUSIVE PARTNERS
  • Perkin Elmer
  • Sngene Lab
  • Genique lifesciences

Genomics throughout Life

Genomic testing is useful in many stages in life, right from pregnancy planning through to old age.

 
Childhood

Some diseases may be due to new (de novo) mutations in a child, that were not present in the parents. Additionally, some parents may not have had the opportunity to have screening testing and may have an affected child even though they themselves may not show symptoms. Genomics testing such as our  Newborn Genetic Screening Test, can screen for inherited genetic disorders and may help to confirm a diagnosis.

 
Cancer

 

Our cells are constantly replicating and being replaced by new cells generated by our bodies. Cancer is caused by errors in the genome, known as mutations which can occur randomly when copying, by environmental damage or a genetic predisposition. We offer a range of genomic testing options designed specifically for cancer patients that may help identify specific mutations that are unique to each patient’s cancer and help healthcare providers make informed choices on the best treatment options for their patients, in addition to a wide portfolio of genetic testing tailored for commercial targeted therapies provided by oncology pharmaceutical sector.

 
Inherited Disease Screening

 

For a range of inherited conditions and disorders, symptoms do not always allow for a definitive diagnosis to be made. Basing a diagnosis on clinical symptoms alone can also result in an incorrect or delayed diagnosis. Obtaining an accurate diagnosis through genetic testing can have significant positive outcomes for patients and their health care providers, by clarifying the diagnosis and helping to identify treatment options sooner. It can also assist in identifying the risk of occurrence in family members, who may be carriers of a genetic mutation.  Codex genetics center has one of the largest genetic testing options of any laboratory in Egypt. Our testing range covers over 3,000 genes associated with a whole range of inherited disorders.

 

 

What is Targeted Sequencing?

Codex utilizes targeted sequencing panels, where we look at a select number of genes associated with particular conditions. This enables only part of the genome to be looked at helping to keep costs and turnaround times down, to improve patient outcomes.

Reducing the number of genes, we look at means we can look more in depth at certain genes, sequencing a particular region more than a hundred times and in some cases more than ten thousand times, so that we can be confident in the result obtained.